Kevzara® (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with Polymyalgia Rheumatica
Three times more patients treated with Kevzara achieved sustained remission compared to placebo in Phase…
Month: February 2023
CLINUVEL Launches CYACÊLLE, Next Generation Solar Care
CLINUVEL’s CYACÊLLE CLINUVEL today launched CYACÊLLE, a next generation of polychromatic solar care. CYACÊLLE is…
LG Energy Solution and Honda Break Ground for New Joint Venture EV Battery Plant in Ohio
JEFFERSONVILLE, Ohio, Mar 1, 2023 – (JCN Newswire) – Honda and LG Energy Solution (LGES;…
TESLA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tesla, Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Holly Energy Partners, L.P. Files 2022 Form 10-K
DALLAS–(BUSINESS WIRE)–On February 28, 2023, Holly Energy Partners, L.P. (NYSE: HEP) (the “Partnership”) filed with…
Faraday Future Announces Stockholder Approval of Proposal to Increase the Authorized Shares of Faraday Future Class A Common Stock
Stockholders also voted in favor of the Yorkville share issuance proposal to issue shares in…
Landos Biopharma Announces Transfer of LANCL Portfolio, including Omilancor, LABP-104 and LABP-111 to Landos’ Founder
Transaction Solidifies Company’s Near-Term Strategic Focus on Advancing Clinical Development of NX-13 Company Remains On-Track…
Landos Biopharma Announces Transfer of LANCL Portfolio, including Omilancor, LABP-104 and LABP-111 to Landos’ Founder
Transaction Solidifies Company’s Near-Term Strategic Focus on Advancing Clinical Development of NX-13 Company Remains On-Track…
Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
THE WOODLANDS, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will…
Lexicon Pharmaceuticals to Host Fourth Quarter 2022 Financial Results Conference Call and Webcast on March 2, 2023
THE WOODLANDS, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will…
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time…
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time…
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM –…
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM –…
Atlas Global Announces Change of Auditor and Year End
EDMONTON, ALBERTA, CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, Feb. 28, 2023 (GLOBE NEWSWIRE) — Atlas Global…
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Atlas Global Announces Change of Auditor and Year End
EDMONTON, ALBERTA, CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, Feb. 28, 2023 (GLOBE NEWSWIRE) — Atlas Global…
GENFIT Announces Revenues and Cash Position as of December 31, 2022
Cash, cash equivalents and current financial instruments totaled €140.2 million as of December 31, 2022….
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…